In 2020, CDER approved two new therapies for neuromyelitis optica spectrum ailment. Ga sixty eight PSMA-eleven (accredited without trade title), a positron emission tomography (PET) imaging agent for detection and localization of prostate most cancers, a substantial advance which offers a far more exact imaging selection for individuals with prosta